Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/28 - 12:00
People with inflammatory bowel disease (IBD) or Parkinson’s disease have depletions in similar types of beneficial bacteria, which could help explain the link between both conditions, a new microbiome study has found.
Date: 2025/03/27 - 18:00
Although measles is seen as a contagious viral disease that passes quickly, it can also cause damage that leaves long-term health effects. A measles infection can lead to a phenomenon called 'immune amnesia,' which affects the body's ability to fight off other infections.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.